News & Events
News & Events
April 14, 2021
CPTA Welcomes Triplet Therapeutics Chief Medical Officer as Industry Co-DirectorC-Path’s Critical Path to Therapeutics for the Ataxias Consortium is pleased to announce the appointment of Irina Antonijevic, M.D., Ph.D., as the consortium’s Industry Co-Director. Irina has worked in drug development for over 18 years, with a focus on translational medicine and early development in neuroscience, but also ophthalmology and immunology. She has gained experience...
April 12, 2021
C-Path’s Alzheimer’s Disease Consortium Expands Data Repository
TUCSON, Ariz., April 12, 2021 — The Critical Path Institute’s (C-Path) Critical Path for Alzheimer’s Disease (CPAD) Consortium today announced that it is significantly expanding its Alzheimer’s disease (AD) patient-level data repository with high-quality contemporary industry clinical trial datasets, focusing on early stages of the disease.
April 8, 2021
CP-SCD Announces Pfizer Executive as its First Industry Co-DirectorC-Path’s Critical Path to Sickle Cell Disease Consortium (CP-SCD) is pleased to announce Dr. David Readett of Pfizer as its first Industry Co-Director. David is a pediatrician/pediatric hematologist/oncologist who, prior to transitioning to clinical research in the pharmaceutical industry, spent 18 years in clinical practice, with a focus on clinical care and research for pediatric...
April 6, 2021
C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate DirectorC-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science Consortium. D-RSC is currently engaged in several modeling projects of biomarkers and outcome measures, all at different stages in development and regulatory review, as well as development of a platform trial protocol for Duchenne and considering a new patient reported outcome instrument....
March 31, 2021
Cures Within Reach Names CURE ID as 2021 Patient Impact AwardeeCures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has awarded CURE ID at the FDA and NCATS/NIH as the recipient of the 2021 Golan Christie Taglia Patient Impact Philanthropy Award part of its 2021 Patient Impact Award recipients of the Global Health Repurposing Awards. C-Path’s Cure Drug Repurposing Collaboratory (CDRC),...